↧
Image may be NSFW.
Clik here to view.
Clik here to view.
Halozyme Pursues Anti-Cellulite Drug, Optimer’s Antibiotic Kills C. Difficile...
Denise Gellene There was a steady flow of drug development and funding news from San Diego’s life sciences industry over the past week. Here are the highlights. —Halozyme Therapeutics (NASDAQ: HALO)...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News
Bruce V. Bigelow The price of shares at San Diego’s Gen-Probe, Amylin Pharmaceuticals, and Optimer were clipped for various reasons over the past week, but several local startups successfully raised...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Feds Scrutinizing Stock Grant to Former Optimer Chairman
Bruce V. Bigelow San Diego’s Optimer Pharmaceuticals (NASDAQ: OPTR) said yesterday the filing of its official annual 10-K financial statement would be delayed because of a management shakeup disclosed...
View Article